Consistent with the requirement of HDAC3 in neurodegeneration is the finding of protection by HDAC1/HDAC3-selective inhibitors against neuropathology and behavioral deficits in mouse models of HD and Fredereich’s ataxia [7, 16, 17]. This evidence concerns the gene HDAC1 and Huntington disease.